BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2664953)

  • 1. Mutation in ras proto-oncogenes and malignancy.
    Marshall CJ
    J UOEH; 1989 Mar; 11 Suppl():398-405. PubMed ID: 2664953
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].
    Müller-Tidow C; Steur C; Mizuki M; Schwäble J; Brandts C; Berdel WE; Serve H
    Dtsch Med Wochenschr; 2002 Oct; 127(42):2195-200. PubMed ID: 12397548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenes and their mechanisms of action.
    Găldean D
    Roum Arch Microbiol Immunol; 1992; 51(1-2):75-99. PubMed ID: 1457825
    [No Abstract]   [Full Text] [Related]  

  • 4. The cell biology of ras-induced transformation: insights from studies utilizing an inducible hybrid oncogene system.
    Haliotis T; Trimble W; Chow S; Mills G; Girard P; Kuo JF; Govindji N; Hozumi N
    Anticancer Res; 1988; 8(5A):935-45. PubMed ID: 2845854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ras mutations in human leukemia and related disorders.
    Greenberger JS
    Int J Cell Cloning; 1989 Nov; 7(6):343-59. PubMed ID: 2681441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
    Ulkü AS; Schäfer R; Der CJ
    Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the mechanisms of transformation through analysis of revertant cells.
    Bassin RH; Benade LE
    Immunol Ser; 1990; 51():15-47. PubMed ID: 2095917
    [No Abstract]   [Full Text] [Related]  

  • 8. PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase.
    Cacace AM; Ueffing M; Philipp A; Han EK; Kolch W; Weinstein IB
    Oncogene; 1996 Dec; 13(12):2517-26. PubMed ID: 9000126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
    Shen S; Passioura T; Symonds G; Dolnikov A
    Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells.
    Chi S; Kitanaka C; Noguchi K; Mochizuki T; Nagashima Y; Shirouzu M; Fujita H; Yoshida M; Chen W; Asai A; Himeno M; Yokoyama S; Kuchino Y
    Oncogene; 1999 Apr; 18(13):2281-90. PubMed ID: 10327074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.
    Gallagher AP; Burnett AK; Bowen DT; Darley RL
    Cancer Res; 1998 May; 58(9):2029-35. PubMed ID: 9581849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transduction. Prelude to an anniversary for the RAS oncogene.
    Downward J
    Science; 2006 Oct; 314(5798):433-4. PubMed ID: 17053139
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of normal and mutant ras proteins in human acute leukemia.
    Shen WP; Aldrich TH; Venta-Perez G; Franza BR; Furth ME
    Oncogene; 1987 May; 1(2):157-65. PubMed ID: 3325880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
    Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
    Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of myeloid cell growth by distinct effectors of Ras.
    Matsuguchi T; Kraft AS
    Oncogene; 1998 Nov; 17(21):2701-9. PubMed ID: 9840934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
    Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
    Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ras p21 and signal transduction].
    Kishi K; Tanaka K; Takai Y
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1107-21. PubMed ID: 8512342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TATA box-binding protein-associated factor 12 is important for RAS-induced transformation properties of colorectal cancer cells.
    Voulgari A; Voskou S; Tora L; Davidson I; Sasazuki T; Shirasawa S; Pintzas A
    Mol Cancer Res; 2008 Jun; 6(6):1071-83. PubMed ID: 18567809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.